News

Shares in London-listed drugmakers GSK and Astrazeneca tumbled on Monday morning after President Donald Trump said the US’ ...
A federal appeals court on Thursday shut down AstraZeneca’s challenge to the U.S. government’s program that gives the ...
AstraZeneca has opened its first U.S.-operated cell therapy manufacturing facility in Rockville, Maryland, as part of its ...
AstraZeneca opens a $300 million cell therapy manufacturing facility in Rockville, boosting the local biotech industry.
The facility, which will produce cell therapies used to treat cancer and auto immune diseases, creates 150 jobs for highly ...
As it applies to the development of cell therapies, AstraZeneca’s chief of global operations, Pam Cheng, admits that the ...
The company removed experimental drugs for Alzheimer’s, migraine and pain from its pipeline to focus more resources on “core ...
The drugmaker posted increased core earnings per share and sales for the first quarter, but also said it could face a fine of ...
British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the ...
AstraZeneca CEO Pascal Soriot is not overly concerned about the threat of tariffs by the Trump administration on ...
The drugmaker posted increased core earnings per share and sales for the first quarter, but also said it could face a fine of ...
Investors in AstraZeneca plc (Symbol: AZN) saw new options become available today, for the June 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AZN ...